
|Articles|February 1, 2002
Botulinum shows promise for added urologic indications
Jena, Germany-Botulinum toxin has shown promise as a potential therapy for chronic pelvic pain and lower urinary tract dysfunction. In a German study, injection of botulinum toxin type A into the urethral sphincter muscle led to improvement in muscle tone, pain, and urodynamic parameters in patients enrolled.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
3
Study suggests potential diuretic effect with nadofaragene firadenovec
4
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
5











